Finally, while our study is acutely focused on CRC, our findings may have broad spectrum implications as EMI1 copy number losses occur in many cancer types, including breast, ovarian, prostate, and lung, although this remains to be formally tested. This evidence concerns the gene FBXO5 and colorectal carcinoma.